Grace Therapeutics Inc (GRCE)
3.15
+0.05
(+1.61%)
USD |
NASDAQ |
Oct 31, 16:00
3.15
0.00 (0.00%)
After-Hours: 20:00
Grace Therapeutics EBIT Margin (TTM)
EBIT Margin (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EBIT Margin (TTM) Data
| Date | Value |
|---|---|
| February 29, 2016 | -- |
| November 30, 2015 | -- |
| August 31, 2015 | -- |
| May 31, 2015 | -- |
| February 28, 2015 | -- |
| November 30, 2014 | -- |
| August 31, 2014 | -- |
| Date | Value |
|---|---|
| May 31, 2014 | -- |
| February 28, 2014 | -- |
| November 30, 2013 | -- |
| August 31, 2013 | -- |
| May 31, 2013 | -- |
| February 28, 2013 | -- |
| November 30, 2012 | -- |
EBIT Margin Definition
An EBIT Margin is the operating earnings over operating sales. This margin allows investors to understand true business costs of running a company, because parts of a company's property, plant, and equipment will eventually need to be replaced as they get used, broken down, decayed, etc.
EBIT Margin (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median